3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
20
Cisplatin
17
pembrolizumab
11
Magnetic Resonance Spectroscopy
7
durvalumab
5
Platinum
5
Irinotecan
5
Fluorouracil
5
1,2-diaminocyclohexaneplatinum II citrate
5
Leucovorin
4
Taxes
3
Oxaliplatin
3
Nivolumab
3
Fluorodeoxyglucose F18
3
Carboplatin
3
Biopsy
3
Bevacizumab
3
spartalizumab
2
pemigatinib
2
ivosidenib
2
fludarabine
2
budigalimab
2
atezolizumab
2
Specimen Handling
2
Radiosurgery
2
Paclitaxel
2
Immunoglobulin G
2
Floxuridine
2
FAPI-46
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Cholangiocarcinoma
×
NUC-1031
×
Clear all
NCT02351765
2023-05-17
ABC-08
The Christie NHS Foundation Trust
Phase 1
Completed
21 enrolled